Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
31.58
-0.50 (-1.56%)
May 12, 2026, 4:08 PM HKT
-1.31% (1Y)
| Market Cap | 4.37B |
| Revenue (ttm) | 102.38K -95.8% |
| Net Income | -145.79M |
| EPS | -1.24 |
| Shares Out | 136.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 64,000 |
| Average Volume | 102,535 |
| Open | 32.50 |
| Previous Close | 32.08 |
| Day's Range | 31.36 - 32.50 |
| 52-Week Range | 13.48 - 32.94 |
| Beta | 0.84 |
| RSI | 58.10 |
| Earnings Date | Mar 27, 2026 |